Yu-Waye Chu is Chief Medical Officer of CytomX Therapeutics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
CytomX Therapeutics, Inc.
19 Jan 24
4
CytomX Therapeutics, Inc.
20 Jul 23
3
CytomX Therapeutics, Inc.
20 Jul 23
4
FATE THERAPEUTICS INC
19 Apr 23
144
FATE THERAPEUTICS INC
18 Apr 23
4
FATE THERAPEUTICS INC
7 Feb 23
4
FATE THERAPEUTICS INC
11 Jan 23
4
FATE THERAPEUTICS INC
21 Apr 22
4
FATE THERAPEUTICS INC
27 Jan 22
4
FATE THERAPEUTICS INC
13 Jan 22
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 18 Jan 24 | CTMX CytomX Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 26,250 | 0.00 | 26,250 |
| 18 Jan 24 | CTMX CytomX Therapeutics | Performance Stock Units (PSUs) Common Stock | Grant | Acquire A | No | No | 0 | 75,000 | 0.00 | 75,000 |
| 18 Jan 24 | CTMX CytomX Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.68 | 122,500 | 205.80 k | 122,500 |
| 19 Jul 23 | CTMX CytomX Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.82 | 375,000 | 682.50 k | 375,000 |